Cerity Partners LLC Raises Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Cerity Partners LLC grew its position in Select Medical Holdings Co. (NYSE:SEM) by 4.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,434 shares of the health services provider’s stock after buying an additional 2,835 shares during the period. Cerity Partners LLC’s holdings in Select Medical were worth $2,177,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Citigroup Inc. increased its stake in Select Medical by 85.3% during the third quarter. Citigroup Inc. now owns 140,703 shares of the health services provider’s stock worth $4,906,000 after acquiring an additional 64,751 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Select Medical by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after purchasing an additional 24,439 shares during the last quarter. Foundry Partners LLC raised its holdings in Select Medical by 3.6% in the 3rd quarter. Foundry Partners LLC now owns 245,860 shares of the health services provider’s stock valued at $8,573,000 after buying an additional 8,561 shares during the period. Intech Investment Management LLC lifted its position in Select Medical by 39.7% in the third quarter. Intech Investment Management LLC now owns 24,720 shares of the health services provider’s stock valued at $862,000 after buying an additional 7,021 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in Select Medical during the third quarter worth about $1,320,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Analyst Ratings Changes

SEM has been the topic of several recent analyst reports. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. Royal Bank of Canada raised their price target on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Finally, Bank of America assumed coverage on Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price on the stock.

Insider Buying and Selling at Select Medical

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 19.14% of the company’s stock.

Select Medical Price Performance

Select Medical stock opened at $21.11 on Monday. The company’s 50 day moving average is $34.11 and its two-hundred day moving average is $34.71. The firm has a market cap of $2.73 billion, a PE ratio of 9.86, a price-to-earnings-growth ratio of 0.94 and a beta of 1.42. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical Holdings Co. has a 52-week low of $20.00 and a 52-week high of $40.98.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. Select Medical’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.46 EPS. On average, research analysts expect that Select Medical Holdings Co. will post 2.16 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were paid a $0.125 dividend. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a yield of 2.37%. Select Medical’s dividend payout ratio is currently 23.36%.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.